Review Article
Mariana Najara Rosa Rodrigues
Mariana Najara Rosa Rodrigues
Discente do Curso de Biomedicina do
Centro Universitário Avantis – UNIAVAN - Av. Marginal Leste, 3600, Estados, Balneário
Camboriú–SC, CEP: 88339125, Brazil.
And
Department of Biomedical Sciences,
Centro Universitário Avantis – UNIAVAN - Av. Marginal Leste, 3600, Estados,
Balneário Camboriú – SC, CEP: 88339125, Brazil.
Rodrigo Cé*
Rodrigo Cé*
Corresponding Author
Coordenador e Professor do Curso de
Biomedicina do Centro Universitário Avantis – UNIAVAN - Av. Marginal Leste,
3600, Estados, Balneário Camboriú – SC, CEP: 88339125, Brazil.
And
Department of Biomedical Sciences,
Centro Universitário Avantis – UNIAVAN - Av. Marginal Leste, 3600, Estados,
Balneário Camboriú – SC, CEP: 88339125, Brazil.
E-mail: rodrigoce@uniavan.edu.br, Tel: +55
51 981409716
Received: 2024-10-28 | Revised:2024-11-21 | Accepted: 2024-11-21 | Published: 2024-11-30
Pages: 57-72
DOI: https://doi.org/10.56717/jpp.2024.v03i02.027
Abstract
Telomeres are essential structures located at the ends of eukaryotic chromosomes, composed of G-rich repeats, which play a crucial role in protecting chromosomal ends. Telomere shortening is associated with genetic instability and cellular senescence. This review study aims to investigate the role of telomerase in cellular senescence and skin aging. The methodology involved a qualitative exploratory literature review, with research conducted in databases such as PubMed, Web of Science, and Google Scholar. Telomeres protect the ends of eukaryotic chromosomes, and their dysfunction leads to cellular senescence. Telomerase, a ribonucleoprotein, regulates telomere length and is crucial for cellular longevity. However, dysregulated telomerase expression may be associated with pathologies such as cancer. Oxidative stress accelerates telomere shortening and contributes to cellular aging. The analysis revealed a growing trend of publications related to telomeres and telomerase, with peaks in 2020 and 2017, respectively. Cellular senescence showed consistent growth, and exogenous telomerase expression demonstrated therapeutic potential, albeit with associated risks. Telomeres and telomerase play essential roles in regulating cell division and longevity. Telomerase is crucial for preserving cellular function, but its dysregulated expression can lead to pathologies. Oxidative stress accelerates cellular senescence, and research on exogenous telomerase expression highlights both potential and challenges for anti-aging therapies. Understanding these mechanisms is essential for developing effective strategies to promote cellular health and treat age-related diseases.
Abstract Keywords
Telomeres, telomerase, cellular senescence, skin
aging, oxidative stress.
1.
Introduction
Skin aging is a multifactorial biological process characterized by a
series of structural, molecular, and functional changes over time, influenced
by various intrinsic and extrinsic factors. Similar to the aging of other
organs, the skin gradually loses functionality and regenerative capacity [1]. However, what makes skin aging unique is its
strong susceptibility to external factors such as lifestyle and exposure to
harmful environmental agents [2]. Ultraviolet
radiation, primarily from sunlight, emerges as a major driver of premature skin
aging. This radiation can cause DNA damage and trigger oxidative processes in
skin cells, thus contributing to cellular aging and senescence [3].
Cellular senescence is a key phenomenon in the study of skin aging and
other tissues. Prior to this discovery, it was believed that all cells were
essentially immortal and could replicate indefinitely [4].
Cellular senescence is a state in which cells enter an irreversible cell
cycle arrest in response to various stress factors, such as DNA damage,
oxidative stress, and environmental influences. The accumulation of
dysfunctional and senescent cells in aging tissues has detrimental effects,
impairing their repair and regeneration capacity [5].
In the context of the skin, cellular senescence is associated with a
range of changes and alterations [6].
Telomeres are essential structures located at the ends of eukaryotic
chromosomes, composed of multiple G-rich repeats. In mammals, the repetitive
telomeric sequence is TTAGGG, repeated thousands of times [7]. These structures play a vital role in
protecting chromosomal ends from degradation and being identified as
double-strand breaks. In the absence of telomeres, chromosomes can fuse,
resulting in genetic instability [8]. Telomere
shortening, damage to them, or the expression of mutant proteins that bind to
telomeres can compromise the protective complex, triggering a DNA damage
response and leading to cellular senescence [9].
Due to the inability of standard DNA polymerases to fully replicate
linear DNA models in the absence of telomerase, an independent DNA polymerase
model, and due to nucleolytic processing, DNA replication results in the
formation of chromosomes with progressively shorter telomeres [10]. When telomeres reach a critical length, they
can no longer bind to telomeric covering proteins in sufficient quantity, being
detected as exposed DNA ends. This activates DNA damage response pathways,
which, through the induction of cell cycle inhibitors such as p21 and p16, halt
cell proliferation [9, 11]. Telomere
shortening is widely recognized as an indicator of cellular aging and
replicative senescence, marking the limit of cell replication and the aging
process [12].
This literature review aims to investigate the role of telomerase, an
enzyme responsible for maintaining telomeres, in cellular senescence and skin
aging, seeking to address the following research question: What are the
cellular senescence processes and factors that best explain skin aging?
Providing molecular insights that may aid in developing strategies to combat
skin aging.
2.
Materials and methods
The methodology of this study is a qualitative, exploratory literature
review focused on investigating aspects of cellular senescence. The search used
specific keywords: telomeres, telomere shortening, telomerase, cellular
senescence, skin, and skin aging. These keywords were searched in the U.S.
National Library of Medicine (PubMed), Web of Science, and Google Scholar
databases. Publications from the past 10 years were prioritized, although
relevant older studies were also considered. The study selection process was
carried out in four stages: First, article titles were assessed for relevance
to the research topic. Second, abstracts were analyzed according to predefined
inclusion and exclusion criteria to select the most relevant articles. Third,
full-text articles were reviewed to ensure alignment with the study's
objectives. Finally, a total of 185 articles were identified, with 136 selected
for inclusion in the final database. Inclusion criteria required that articles
be published in English, available in the selected databases, and accessible
for free. Exclusion criteria involved the exclusion of articles published outside
the last 10 years and those that did not address the research objectives. The
final analysis synthesized key findings, offering insights into cellular
senescence, particularly in relation to skin aging.
3. Theoretical framework
3.1
Telomeres and telomerase
The term "telomere" originates from the Greek words
"telos" (end) and "meros" (part). Telomeres are structures
typical of eukaryotic cells found at the ends of linear chromosomes [13]. They play a fundamental role in genome
stability by protecting the ends of linear eukaryotic chromosomes, preventing
their manipulation and recognition by modified DNA enzymes [14]. Additionally, they function to identify
damaged chromosome ends, preserving DNA integrity during repair and
recombination processes [15], and protecting
against oxidative damage [16].
The function of telomeres can vary between species [16]. They serve as markers of aging, with
telomeres being shortened by an average of 50 to 200 base pairs with each cell
division [17]. Maintaining telomere length
homeostasis is crucial for cell survival, as short telomeres can cause DNA
damage, leading to cellular senescence and apoptosis [18].
Several factors are essential for ensuring telomere stability [18], including an enzymatic complex responsible for
their components, known as telomerase, in which the (Telomerase Reverse
Transcriptase) TERT proteins, dyskerin, and the RNA component TR are
fundamental [19].
Telomerase is a human ribonucleoprotein that regulates telomere balance
and chromosomal integrity, being the primary regulator of telomere length in
cells [20]. Most somatic cells lack
sufficient telomerase, resulting in telomere shortening with each cell division
[21]. Telomerase is recruited to chromosomal
ends via a specific complex [22]. Among the
telomerase components, the level of expression of the catalytic component,
TERT, seems to correlate well with enzyme activity [23].
Although some adult somatic cells express telomerase, this is not
common, especially in human cells. For example, activated human cells may
express a transient form. Regardless of telomerase activity, these cells
continue to lose telomeric DNA with each cell division, eventually leading to
senescence. Thus, in some cases, the presence of telomerase is insufficient to
prevent telomere erosion and senescence resulting from DNA replication. On the
other hand, ectopic expression of telomerase may prevent telomere shortening
and replicative senescence in some human cells, such as fibroblasts and
epithelial cells [24, 25].
The specific components of the telomerase enzymatic complex are TERT
(Telomerase Reverse Transcriptase) and TERC (Telomerase RNA Component). TERT is
a catalytic subunit of telomerase that performs its reverse transcription role
by adding repetitive sequences to telomeric DNA using telomerase RNA as a
template, being essential for nucleotide addition at telomere ends. TERC is a
structured molecule with the ability to fold, serving as a template for
telomeric DNA synthesis and aiding in the correct positioning of nucleotide
addition at telomere ends. Additionally, associated proteins such as Dyskerin
help incorporate RNA into the telomerase complex and ensure TERC binds to TERT
correctly, while other proteins like Nop10 and Gar1 are crucial for the
stability and assembly of the telomerase complex, assisting in the formation of
the ribonucleoprotein complex. These components regulate telomere homeostasis
through structural interaction between TERT and TERC [133].
3.2
Telomerase in human skin
According to published data, telomerase is expressed in situ in the
skin, especially in the epidermis, regardless of the individual's age [26]. Exposure of the skin to factors such as UV
rays and other agents results in telomere shortening, interfering with
telomerase activity and causing genetic alterations in melanocytes [27]. Telomerase activity has been associated with
melanoma-related lesions, providing insights into its function and clinical
relevance in this context [28].
Telomerase plays an essential role in maintaining telomere integrity and
has a direct impact on skin health and aging [29]. Its
activity in the skin is considered one of the main characteristics of cellular
aging [30]. In proliferative and germinative
cells, telomerase remains active, renewing tissues [31],
and in human tissues and cells, it is closely linked to the skin's
capacity for renewal and regeneration over time [32].
Numerous studies in the field have explored anti-aging strategies based
on natural chemical molecules as potential telomerase activators, due to their
fundamental role in skin aging and skin health [33,
34]. Therefore, the search for therapies that preserve telomere
integrity and identify strong telomerase activators is of special interest [35]. To develop strategies for preventing and
treating skin aging and skin-related diseases, it is essential to understand
the molecular mechanisms underlying telomerase regulation in the skin [36, 37].
3.3
Interaction between telomeres and oxidative stress
The interaction between telomeres and oxidative stress plays a crucial
role in cellular aging. Cellular damage caused by oxidative stress results in
genomic instability [38, 39], leading to
cellular senescence due to telomere shortening [40].
Studies show that oxidative stress can trigger cellular responses that
lead to senescence by disrupting the cell cycle [41,
42]. One of the main outcomes of oxidative stress is DNA oxidation [43]. Recent research suggests that oxidative
stress accelerates telomere shortening through DNA precursor molecules, and
this DNA oxidation can inhibit telomerase activity, becoming a potential focus
for cancer treatments [44].
Oxidative stress involvement in telomeres is associated with the
progression of aging-related conditions, such as metabolic syndrome [45], and also with the activation of inflammatory
pathways that affect cellular senescence [46], as
well as certain pathological conditions like male infertility [47]. Some studies suggest that oxidative damage
may directly influence telomerase, impeding its function.
Oxidative stress resulting in excessive production of reactive oxygen
species (ROS) can alter cellular signaling pathways that control telomerase
expression, leading to reduced enzymatic activity in adverse ways. This can
cause direct damage to telomeric DNA, promoting degradation and accelerating
telomere shortening [40, 131]. Telomerase
activity can be affected by ROS in various ways, but mainly through damage to
TERT, impairing its ability to interact with RNA and preventing the addition of
new DNA repeats to the telomeres [132].
Understanding the interaction between telomeres and oxidative stress is
fundamental for developing therapeutic interventions aimed at mitigating the
effects of cellular aging. Research indicates that antioxidants and modulators
of oxidative stress may counteract oxidative damage to telomeres [48], reducing chronic inflammation related to
oxidative stress and contributing to the preservation of telomere integrity,
thereby delaying cellular aging [49]. Understanding
the underlying mechanisms of this interaction can expand the possibilities for
non-pharmacological interventions, promoting cellular health [50].
3.4
Exogenous telomerase expression to correct telomere defects
Exogenous expression of telomerase has shown promise for correcting
telomeric defects [51]. Studies demonstrate
that introducing telomerase into human cells helps restore telomere length [52], associating with effective telomere
management and reprogramming of stem cells [51-54], providing an efficient
means to preserve chromosomal integrity [43]. However,
despite the potential benefits, overexpression of this enzyme has been linked
to various pathological conditions, such as cancer and progeria [55, 56].
In cultures of normal human fibroblasts, exogenous expression of TERT
maintains these cells viable in vitro [23]. Therefore,
it is crucial to consider the possible adverse effects of this exogenous
telomerase expression [57]. Studies suggest
that indiscriminate activation of telomerase may increase the risk of malignant
transformation, tumorigenesis, genomic instability, and chromosomal
rearrangements [58], as well as contribute
to the progression of aging-related diseases [59].
Exogenous telomerase expression has emerged as a promising strategy for
cellular rejuvenation therapies and may be used to restore the proliferative
capacity of cells and reduce signs of cellular senescence [134]. However, this application also raises
concerns about potential carcinogenesis risks, as longer telomeres may allow
uncontrolled proliferation of cells with mutations [135].
Additionally, it may lead to genomic instability, compromising genome
integrity and significantly affecting cell functionality in the long term [136].
Various therapeutic approaches are being developed to modulate
telomerase activity, providing potential treatments for aging-related
pathologies and telomeric disorders [60]. With
advances in gene editing technology, specific compounds capable of modulating
telomerase activity have been identified, offering new perspectives for
correcting telomeric defects through direct manipulation of its expression [61]. These approaches, combined with progress in
gene editing technology, allow precise manipulation of telomerase expression,
opening new therapeutic possibilities for correcting telomeric defects [51].
3.5
Telomere dysfunction during aging
Telomere dysfunction during the aging process occurs intrinsically and
complexly, triggering a series of molecular and cellular changes [62]. Over time, telomeres undergo gradual
shortening, becoming chromosomally unstable and compromising cellular functions
[63, 64]. This telomeric shortening is
directly linked to the replicative capacity of cells, leading to cellular
senescence and depletion of cellular reserves over time [65, 66]. Consequently, telomere dysfunction affects tissue and
organ regeneration capacity, contributing to the development of age-related
diseases [67, 68].
In addition to reduced telomere length, dysfunction during aging is also
associated with the activation of cellular stress signaling pathways and
chronic inflammation [69, 70]. This results
in DNA damage that contributes to aging through genomic alterations and
impairment of cellular functions [71, 72]. Telomere
dysfunction is one of the mechanisms that can lead cells to senescence. While
telomere shortening is a significant factor in this process, recent studies
have found that telomeric dysfunction can occur independently of telomere
length [65].
3.6
Histology of the skin and types of skin cells
The skin is the largest organ of the human body and histologically [73], it exhibits a complex organization of specific
layers. The outermost layer of the skin is the epidermis, which is
predominantly composed of stratified squamous epithelium [74]. Keratinocytes, the predominant cells in the
epidermis, form a physical barrier that prevents transepidermal water loss and
protects the body against external agents [75]. Additionally,
the epidermis houses other specialized cells, such as melanocytes, which are
responsible for producing melanin, giving color to the skin and protecting
against ultraviolet radiation damage [76], and
Langerhans cells, which are involved in the skin’s immune response by detecting
and presenting antigens [77, 78].
The dermis, located below the epidermis, is the thickest layer of the
skin, composed of dense connective tissue [75]. It
is divided into two layers: the papillary dermis, made up of loose connective
tissue, and the reticular dermis, the deeper layer composed of dense connective
tissue [76]. In the dermis, fibroblasts are
responsible for the synthesis and maintenance of extracellular matrix
components, such as collagen and elastin fibers, playing a crucial role in
wound healing [76]. Mast cells, part of the
immune system, are also present in the dermis, performing functions related to
inflammatory and allergic responses [75, 78]. Furthermore,
the dermis is characterized by abundant and compact protective keratin,
lamellar or Vater-Pacini corpuscles, Meissner's corpuscles, specialized
arteriovenous communications, and eccrine sweat glands [79,
80].
The hypodermis, located below the dermis, is known as subcutaneous
tissue and is primarily composed of adipose tissue [74].
It contains adipocytes, specialized cells for fat storage and
temperature regulation, as well as blood vessels and nerves responsible for
tissue vascularization [76]. Other important
skin structures include hair follicles and sebaceous and sweat glands, which
play essential roles in temperature regulation and skin lubrication [81, 82]. Hair follicles consist of different
types of cells, including stem cells, matrix cells, and hair pressure cells,
which are responsible for hair growth and regeneration [75].
3.7
Cellular senescence
Cellular senescence represents the loss of the capacity for cellular
replication, where the cell cycle is permanently halted. Various stressors can
induce cellular senescence, including oxidative stress, telomere alterations,
mitochondrial dysfunctions, ribosomal stress, epigenetic modifiers,
irradiation, drugs, and oncogenic stress [83]. This
disadvantage is manifested by the interruption of post-mitotic cell division in
response to some type of damage, with telomere shortening being one of the main
factors. However, subsequent studies have revealed other pathways initiated by
stimuli through which cells can enter senescence and cease to proliferate,
regardless of the number of duplications [84].
Different types of senescence include replicative, stress-induced,
oncogene-induced, and developmental senescence. Replicative senescence is
characterized by short telomeres and is influenced by the activation of the
CDKN2A locus, which encodes the tumor suppressor p16, responsible for
inhibiting CDK4 and CDK6 [85]. Stress-induced
senescence is related to high intracellular levels of reactive oxygen species
(ROS) and results from the RAS-RAF-MEK-ERK cascade, which activates p38 MAPK
and leads to increased transcriptional activity of p53 and positive regulation
of p21 [86]. Oncogene-induced senescence is
marked by the activation of the CDKN2A15 locus, leading to abnormal DNA
replication. Developmental senescence is normal and necessary for the formation
of certain human organs, such as neural tube closure and gallbladder formation
during embryonic development [85].
Recent discoveries are shifting the perspective on cellular senescence,
viewing it as a stimulus for tissue alteration processes and also as a
mechanism for eliminating unwanted cells following tissue damage. Senescent
cells eliminate their deficiencies and recruit immune cells, promoting tissue
renewal. If these senescence phases do not occur effectively, it can result in
the accumulation of senescent cells in the organism [87].
3.8
Cellular senescence of various skin cell types
Senescent cells exhibit four interdependent aspects, as described by the
International Cellular Aging Society (ICSA): permanent cell cycle arrest, Senescence-Associated
Secretory Phenotype (SASP), macromolecular damage, and dysregulated metabolism [83]. Senescent cells have been observed in
various types of skin cells [69]. Over time,
senescent cells accumulate in the skin, with histochemical detection of
beta-galactosidase expression in senescent fibroblasts and keratinocytes [88]. This accumulation is considered a reliable
biomarker of aging, contributing to age-related skin changes, expanding the
basal layer of the epidermis, and affecting its regeneration and structure [89].
Studies have shown that in human skin in vivo, during melanocyte
senescence, these cells express a succession of senescence markers, such as
increased p16 INK4A levels over the years [90]. It
has also been found that in aged melanocytes, there is a much higher occurrence
of dysfunctional telomeres, although without telomere shortening, suggesting
that the primary cause of telomere dysfunction in aged melanocytes is not
telomere shortening [65].
3.9
Skin stem cells and their relevance to skin aging
Stem cells can be classified as totipotent, pluripotent, and
multipotent, with these cells varying in capability depending on the organs
they derive from, facilitating tissue regeneration [91].
Researchers have identified and categorized stem cells into two broad
groups: embryonic and adult [92]. The skin
is a tissue in constant self-renewal, and to maintain homeostasis, there are
niches with stem cells responsible for addressing natural cellular losses or
those caused by injuries [93]. In its
outermost compartment, the epidermis, there are indications of epidermal stem
cells. These quiescent cells are located in the most basal layer of the
interfollicular epidermis, attached to the basement membrane through
integrin-class proteins. As these cells migrate to the upper layers, they
undergo differentiation until they reach the skin surface as non-scaly
corneocytes [93].
Stem cells have been linked to the aging process, with oxidative stress caused by reactive oxygen species being the primary effector in the skin. This phenomenon has been more extensively studied in hematopoietic stem cell models, where it was implicated in the activation of the INK4a/ARF locus transcription, leading to the activation of the senescence program. Despite its relevance, the relationship between these pathways and skin stem cell aging remains largely unexplored [93]. Another important stem cell niche is hair. Dermal mesenchymal stem cells are capable of differentiating into adipocytes, chondrocytes, and osteocytes, typically derived from mesodermal precursors [93]. In many tissues, stem cells also progressively lose telomerase activity and, consequently, the ability to maintain tissue renewal, which is one of the main causes of aging [19].
3.10 Cellular senescence and organismal aging
Researchers assert that the terms senescence and aging are used interchangeably, as both refer to cellular transformations that occur in organs and tissues related to the passage of time and biological processes. These processes impair the physiology of the organism, leading to functional effects that make it vulnerable to pathologies [94].
Senescent cells do not die immediately; most remain viable and metabolically active for extended periods in culture, indicating that senescence occurs not only during aging but also naturally throughout the life of organisms [95]. These cells exhibit morphological changes, both in vivo and in vitro, such as increased size with a flattened appearance and numerous vacuoles, the presence of DNA damage “scars,” and alterations in heterochromatin [96].
Senescent cells are distinct from other non-dividing cells, such as quiescent cells, characterized by the absence of proliferative markers like Ki67, as well as other markers like p16, p21, and p27 [97]. Additionally, ß-galactosidase activity associated with senescence is observed, reflecting the expression of tumor suppressors and cell cycle inhibitors. Although none of these markers are completely specific or universal for all types of senescence, senescent cells express most of them [98].
3.11 Cellular senescence and telomeres
Cellular senescence refers to the response of mitotically competent cells, which are not terminally differentiated and thus capable of division, to stimuli that have the potential to cause neoplastic transformations, resulting in, among other aspects, growth arrest [99]. Cellular senescence is not only expressed through a halt in cell growth but also involves functional alterations that, together, define the senescent phenotype. Due to mutated RAS, telomerase cannot prevent senescence in human fibroblasts, indicating that cells can manifest a senescent phenotype independently of specific telomeres [100,101].
When discussing cellular senescence, it is closely associated with telomeres, which are structures containing a short, repetitive DNA sequence (5'TTAGGG3') located at the chromosomal ends of cells with the function of preserving genetic information and bases [102]. Telomeres serve as cellular markers, functioning as an intrinsic counter to protect the organism from uncontrolled cell divisions, undergoing shortening with each division until they lose their function and enter a state of cellular senescence [103].
3.12 Why is cellular senescence important?
Cellular senescence is significant because it represents a permanent proliferative halt in response to various stressors and acts as a tumor-suppressing mechanism. However, it also entails a loss of repair and tissue regeneration capacity due to cell cycle interruption [104]. Cellular senescence plays a crucial endogenous role as an antitumoral mechanism and is related to the activity of antitumoral drugs [105]. Conceptual advancements have been made regarding the role of senescent cells, highlighting the importance of understanding that senescence is not limited to the loss of proliferative capacity but also involves gene expression, epigenome, metabolism, and especially the SASP [106]. Evidence suggests that the senescence response evolved to suppress tumorigenesis, acting as a safety mechanism to prevent cells at risk of undergoing neoplastic transformations. Thus, normal cells undergo senescent arrest when exposed to various stimuli capable of inducing or promoting neoplastic changes [101].
3.13 What are telomeres and how do they signal senescence?
Initial records about telomeres emerged in the 1930s by McClintock and Muller studying the ends of chromosomes in *Zea mays* and *Drosophila melanogaster*. However, it was not until 1961 that Hayflick and Moorhead observed that human fetal cells had a replication capacity of 50 to 60 times, establishing the "Hayflick limit" known as replicative senescence. This was a landmark in scientific history, paving the way for numerous new studies in the field [107].
Telomeres act as protective structures at the chromosomal ends, being highly vulnerable to intrinsic and extrinsic stress factors, affecting cellular health [65]. During DNA replication, telomeres lose genetic material—about 50 to 100 base pairs—leading to their shortening. Both this shortening and the specific proteins associated with it signal the cessation of the cell cycle. Cell death then occurs through chromosomal instability resulting from telomere shortening [108].
Senescence signaling can occur through two pathways: ATR-Chk1 and ATM-Chk2. These pathways phosphorylate Chk1 and Chk2, blocking cell development during the G1/S and G2/M phases by inhibiting CDC25 and suppressing CDK activation. Thus, ATM and ATR promote p53 activation, inhibiting further cell cycle progression [109]. The p53 transcription factor, in its specific sequence, directs the expression of target genes that respond to cellular stress and damage [110].
Senescent cells also produce molecules that are pro-inflammatory and degradative to the extracellular matrix, known as the SASP. SASP is primarily initiated by inflammatory cascades mediated mainly by NF-κB and p38 MAPK signaling and is autocrinely inhibited [104]. One of the main functions of SASP is to recruit the immune system to eliminate senescent and tumor cells, but SASP also induces cellular plasticity and tissue regeneration [111].
3.14 Telomere dysfunction can occur independently of length
Additionally, not only the reduction in telomere length but also changes in their structure and function can result in cellular senescence or apoptosis, leading to organ dysfunctions [112]. Telomere damage unrelated to length has been recently proposed as a mechanism of slow or post-mitotic cellular senescence, showing low proliferative potential in vivo and harboring dysfunctional telomeres without significant shortening [69].
Therefore, telomeric length can be considered an important biomarker of aging or even a mitotic clock partially responsible for this process, with telomere shortening and consequent dysfunction being related to the development of various chronic diseases [113,114]. An increased population of senescent cells in specific tissues, resulting from telomere shortening or dysfunction, has been associated with various aging-related phenotypes, including cardiovascular and metabolic diseases and changes in cognitive performance [115]. Shortened telomeres are associated with a 3.2-fold increase in cardiovascular disease mortality and an 8.5-fold increase in infectious disease mortality [116].
3.15 Skin aging
Aging occurs gradually, affecting all organs, with the skin being no exception. Skin aging can be classified as chronological, also known as intrinsic aging, which is influenced by genetic factors and occurs with age, or extrinsic aging, which results from external factors [117]. Extrinsic factors include environmental elements that damage skin health, such as UV radiation, the primary and most significant factor contributing up to 80% to skin aging, along with other factors such as smoking, alcohol consumption, and poor diet [109].
Intrinsic factors related to skin aging are characterized by genetic and/or metabolic changes that lead to collagen loss and even tissue degeneration. This intrinsic skin aging is marked by the atrophy of structural components, with decreased dermal density, reduced vascularization, changes in the dermal-epidermal junction, and a reduction in the number and size of epithelial cells [118]. Various intrinsic factors, such as genetically programmed lifespan, or extrinsic factors like the accumulation of radiation damage, result in gradual phenotypic and functional changes in cells. These changes lead to senescence, characterized by prolonged and sometimes irreversible cell cycle arrest [119].
Aging brings biochemical changes that cause clinical manifestations in the skin, such as increased thickness, pigmentation, and wrinkles. Some of these changes involve alterations in immune system functions, skin appendages, DNA components, and the balance between oxidative and antioxidant species, often resulting from oxidative stress [117].
3.16 Genetic diseases and skin aging
Genetic diseases are caused by mutations in genes that encode telomerase complex proteins or are involved in other telomere maintenance processes [120]. Gene expression also changes with age, influencing matter production. Additionally, telomeres shorten, and external factors can impact the aging process [121]. Oxidative stress causes mutations, leading to telomere shortening, lipid alterations through lipid peroxidation, and oxidative damage to DNA and proteins. Another factor to consider is free radicals, which can damage DNA by increasing genetic damage and reducing telomere repair [48]. Cellular damage associated with aging includes distorted nuclei and Golgi complexes, as well as inefficient mitochondria. Over a lifetime, cellular degeneration increases, and mitochondrial functionality, responsible for cellular respiration, diminishes ATP production with aging [121].
Aging in humans and most species is also associated with genetic variants. A group of European scientists is analyzing over 500,000 genetic variations. According to Nilesh Samani, a cardiology professor and one of the study coordinators, biological aging can cause cells to appear younger or older than the actual age of the individual [122]. Telomeres can be seen as protective caps at the ends of shoelaces; when this protection is damaged, the shoelace threads begin to fray. This analogy explains the importance of preserving telomeres for chromosome stability. Thus, repetitive DNA sequences (at the end of chromosome) known as telomeres, wear down, leaving the genetic material unprotected, and significant cell renewal does not occur [121].
4. Results and discussion
Based on the results obtained from the search using keywords such as telomeres, telomere shortening, telomerase, cellular senescence, skin, and skin aging, available in the PubMed and Google Scholar databases, a notable trend was observed in the number of articles published over the past ten years. This trend is illustrated in the following comparative analysis, represented in graphs (Fig. 1). The graphs (Fig. 1) reveal a significant variation in the number of documents published across the two databases. For telomerase, there was an initial growth in the first years, visible in both databases, with a peak in 2020 on PubMed (133 publications) and in 2017 on Google Scholar (228 publications) (Fig. 1). After these peaks, the numbers stabilized and began to decrease from 2021 onward. Regarding telomere shortening, there was a reduced number of publications. Initially, there was fluctuation in the early years, with a significant increase in 2021 in both databases (43 articles in PubMed and 76 in Google Scholar) (Fig. 1). Since then, there has been a gradual reduction, with a more pronounced decline on PubMed compared to Google Scholar. For telomerase, the analysis shows a significant initial increase (Fig. 1), reaching 327 publications on PubMed and 574 on Google Scholar in 2015, followed by a progressive decline in both cases in recent years.
Figure 1. Representation of the research results, with
keywords found in PubMed and Google Scholar, comparing the publication year and
the number of publications: A) Telomeres, B) Telomere shortening, C)
Telomerase, D) Cellular senescence, E) Skin, and F) Skin aging.
For cellular senescence, there was consistent growth over the decade, with a notable peak in 2023 (382 publications on PubMed and 591 on Google Scholar), followed by a slight reduction in 2024, with a few months still pending publication (Fig. 1). Concerning skin, there were many publications with a clear trend of expansion in academic production. PubMed recorded a peak of 8,265 publications, while Google Scholar reached a remarkable total of 20,500 publications in 2023 (Fig. 1). For skin aging, the numbers were relatively low, especially on PubMed, which peaked at 100 publications in 2022, while Google Scholar reached 330 publications the following year, suggesting a slight expansion compared to earlier years (Fig. 1). The data indicate a general trend of growth in the number of scientific articles published in both databases over the past ten years, highlighting an increase in research activity. Google Scholar demonstrated a broader coverage, resulting in a higher number of publications compared to PubMed, which is more focused on medical and health sciences literature. However, both databases show efficacy in the reliability of their publications and reflect their respective emphases and scopes.
Skin aging is a complex phenomenon caused by a variety of intrinsic and extrinsic factors, resulting in significant functional and structural changes in the skin. One of the main aspects of this process is cellular senescence, characterized by permanent cell cycle arrest, directly related to telomere shortening. Located at the ends of chromosomes, telomeres primarily function to protect chromosomes, preventing their degradation and ensuring genetic stability. With each cell division, telomeres progressively shorten due to the inability of DNA polymerases to fully replicate this region. This gradual shortening leads to a point where the cell enters senescence, halting its ability to divide and proliferate [10, 123, 124].
The enzyme responsible for maintaining telomeres is telomerase, which adds repetitive sequences to telomeres, helping to ensure their integrity and prevent cellular senescence. However, telomerase activity is typically low in mature somatic cells, limiting tissue renewal capacity and contributing to skin aging. Studies suggest that reactivation of telomerase may influence the reversal of aspects of cellular senescence and promote tissue regeneration [24,125,126].
Extrinsic factors, such as UV radiation exposure, accelerate skin aging by causing oxidative stress and DNA damage, accelerating telomere shortening, and contributing to cellular senescence. UV radiation also promotes the production of reactive oxygen species (ROS), which elevate oxidative stress and stimulate aging. Thus, environmental stress and intrinsic aging mechanisms, such as telomere shortening, lead to the deterioration of skin function and structure. The combination of extrinsic stress with intrinsic mechanisms results in telomere shortening and skin aging [127,128].
Understanding the role of telomerase in cellular senescence and its impact on skin aging is crucial for developing new interventions aimed at increasing telomerase activity, inhibiting cellular senescence, and potentially slowing skin aging while improving its condition. Recent studies suggest that modulation of telomerase activity through genetic or pharmacological therapies may offer new approaches in combating skin aging and conditions related to cellular senescence [33,129,130].
5. Conclusions and future directions
The detailed analysis of telomeres, telomerase, and their roles in cellular senescence and skin aging underscores their pivotal role in maintaining cellular stability and longevity. Telomeres protect chromosomal ends and regulate cellular division, while telomerase activity is vital for preserving telomere length and cellular function. Dysregulation of telomerase expression, however, can lead to diseases such as cancer. The role of oxidative stress in accelerating telomere shortening and cellular senescence further emphasizes the importance of antioxidant strategies to safeguard telomere integrity. Additionally, telomeric dysfunction, although central to aging, is part of a broader and more complex mechanism of cellular senescence. Research into exogenous telomerase expression holds promise for therapeutic interventions, yet challenges remain in safely manipulating these pathways for anti-aging purposes. Looking ahead, future research should focus on exploring more precise methods to regulate telomere length and telomerase activity without triggering unwanted side effects, such as tumorigenesis. Further studies into the interactions between oxidative stress and telomere dynamics could lead to innovative antioxidant therapies. Additionally, a deeper understanding of the molecular mechanisms underlying cellular senescence could reveal new targets for combating age-related diseases. Ultimately, developing effective strategies to modulate telomere biology will be essential for advancing therapeutic interventions aimed at promoting cellular health and mitigating the effects of aging.
Authors’ contributions
Investigation, conceptualization, methodology and writing - original draft, M.N.R.R; Conceptualization, formal analysis, writing-reviewing, editing, supervision and validation, R.C.
Acknowledgements
The authors don't have anything to acknowledge.
Funding
We would like to thank UNIAVAN for its financial support.
Availability of data and materials
All data will be made available on request according to the journal policy.
Conflicts of interest
The authors declare no conflict of interest.
References
|
1. |
Rittie, L.; Fisher, G.J. Natural and
sun-induced aging of human skin. Cold Spring Harb. Perspect. Med. 2015, 5(1), a015370, https://doi.org/10.1101/cshperspect.a015370 |
|
2. |
Gruber, F.; Kremslehner,
C.; Eckhart, L.; Tschachler, E. Cell aging and cellular senescence in skin
aging - Recent advances in fibroblast and keratinocyte biology. Exp.
Gerontolog. 2020, 130, 110780. https://doi.org/10.1016/j.exger.2019.110780 |
|
3. |
Cavinato, M.; Jansen-Dürr,
P. Molecular mechanisms of UVB-induced senescence of dermal fibroblasts and
its relevance for photoaging of the human skin. Exp. Gerontolog. 2017, 94,
78-82. https://doi.org/10.1016/j.exger.2017.01.009 |
|
4. |
Bulbiankova, D.;
Díaz-Puertas, R.; Álvarez-Martínez, F.J.; Herranz-López, M.;
Barrajón-Catalán, E.; Micol, V. Hallmarks and biomarkers of skin senescence:
an updated review of skin senotherapeutics. Antioxidants, 2023, 12(2), 444. https://doi.org/10.3390/antiox12020444 |
|
5. |
Ho, C.Y.; Dreesen, O.
Faces of cellular senescence in skin aging. Mech. Ageing Dev. 2021, 198,
111525, https://doi.org/10.1016/j.mad.2021.111525 |
|
6. |
Csekes, E.; Račková, L.
Skin aging, cellular senescence and natural polyphenols. Int. J. Mol. Sci.
2021. 22(23) 12641. https://doi.org/10.3390/ijms222312641 |
|
7. |
Moyzis, R.K.; et al. A
highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres
of human chromosomes. Proceedings of the National Academy of Sciences of the
United States of America, 1988, 85(18), 6622-6626. https://doi.org/10.1073/pnas.85.18.6622 |
|
8. |
O'sullivan, R.J.;
Karlseder, J. Telomeres: protecting chromosomes against genome instability.
Nat. Rev. Mol. Cell Biol. 2010,
11(3), 171-181. https://doi.org/10.1038/nrm2848 |
|
9. |
D'adda Di, F.F.; et al. A
DNA damage checkpoint response in telomere-initiated senescence. Nature.
2003, 426 (6963), 194-198. https://doi.org/10.1038/nature02118 |
|
10. |
Harley, C.B.; Futcher, A.B.; Greider, C.W.
Telomeres shorten during ageing of human fibroblasts. Nature, 1990, 345 (6274), 458-460. https://doi.org/10.1038/345458a0 |
|
11. |
Herbig, U.; et al. Telomere shortening
triggers senescence of human cells through a pathway involving ATM, p53, and
p21CIP1, but not p16INK4a. Mol. Cell. 2004, 14, 501-513. https://doi.org/10.1016/s1097-2765(04)00256-4 |
|
12. |
D'avila, J. Da C.; et al. Mecanismos moleculares
do envelhecimento: revisão da literatura. Revista Brasileira de Ciências do
Envelhecimento Humano. 2020, 17, 1. https://doi.org/10.5335/rbceh.v17i1.10543 |
|
13. |
Félix, Nathália Quaiatto. Papel da obesidade, do
estilo de vida e dos fatores imunológicos no comprimento dos telômeros em
crianças e adolescentes. 2024. |
|
14. |
Wood, A.M.; et al. A
beginning of the end: new insights into the functional organization of
telomeres. Nucleus. 2015, 6(3), 172-178. https://doi.org/10.1080/19491034.2015.1048407 |
|
15. |
Bryan, T.M.
G-Quadruplexes at telomeres: friend or foe? Molecules. 2020, 25(16), 3686. https://doi.org/10.3390/molecules25163686 |
|
16. |
Olsson, M.; Wapstra, E.;
Friesen, C.R. Evolutionary ecology of telomeres: a review. Ann. New York
Acad. Sci. 2018, 1422, 5-28. https://doi.org/10.1111/nyas.13443 |
|
17. |
Grill, S.; Nandakumar, J.
Molecular mechanisms of telomere biology disorders. J. Biol. Chem. 2021. 296, 100064. https://doi.org/10.1074/jbc.REV120.014017 |
|
18. |
Greider, C.W. Regulating
telomere length from the inside out: the replication fork model. Gen. Dev.
2016, 30(13), 1483-1491. https://doi.org/10.1101/gad.280578.116 |
|
19. |
Perona, R. et al.
Molecular diagnosis and precision therapeutic approaches for telomere biology
disorders. In: Larramendy, M.; Soloneski, S. (Ed.). Telomeres: a complex end
of the chromosome. 2015. https://doi.org/10.5772/65353 |
|
20. |
Schmidt, J. C.; Cech,
T.R. Human telomerase: biogenesis, trafficking, recruitment, and activation.
Gen. Dev. 2015, 29(11), 1095-1105. https://doi.org/10.1101/gad.263863.115 |
|
21. |
Bernardes D.J.B.; Blasco,
M.A. Telomerase at the intersection of cancer and aging. Trend. Gen. 2016,
32(8), 442-450. https://doi.org/10.1016/j.tig.2013.06.007 |
|
22. |
Bernal, A.; Tusell, L.
Telomeres: implications for cancer development. Int. J. Mol. Sci. 2018, 19(1)
294. https://doi.org/10.3390/ijms19010294 |
|
23. |
Baek, S.; et al.
Telomerase induction in astrocytes of Sprague-Dawley rat after ischemic brain
injury. Neurosci. Lett. 2015, 610, 54-59. https://doi.org/10.1016/j.neulet.2004.03.059 |
|
24. |
Shay, J.W.; Wright, W.E.
Telomeres and telomerase: implications for cancer and aging. Rad. Res. 2015,
183(2), 129-142. https://doi.org/10.1667/0033-7587(2001)155[0188:TATIFC]2.0.CO;2 |
|
25. |
Leung, K.; Pereira-Smith,
O.M. Identification of genes involved in cell senescence and immortalization:
potential implication for tissue aging. Novart. Found. Symp. 2015, 344,
205-217. https://doi.org/10.1002/0470868694.ch10 |
|
26. |
Babizhayev, M.A.
Treatment of skin aging and photoaging with innovative oral dosage forms of
nonhydrolized carnosine and carcinine. Int. J. Clin. Dermatol. Res. 2017,
5(5), 116-143, https://doi.org/10.19070/2332-2977-1700031 |
|
27. |
De, S.S.C.P.; et al. Azidotimidina (AZT) na expressão gênica e na síntese proteíca da
telomerase em células de melanoma metastático humano / Azidothymidine (AZT)
in gene expression and protein synthesis of telomerase in human metastatic
melanoma cells. Braz. J. Dev. 2022, 8(5),
40646-40661. https://doi.org/10.34117/bjdv8n5-415 |
|
28. |
Carvalho, L.M.Y. Atividade de telomerase nas
lesões melanocíticas e na pele: correlação com aspectos histopatológicos do
melanoma. 2000. |
|
29. |
Shay, J.W. Role of
telomeres and telomerase in aging and cancer. Cancer Discover. 2016, 6(6),
584-593. https://doi.org/10.1158/2159-8290.CD-16-0062 |
|
30. |
López-Otín, C.; et al.
The hallmarks of aging. Cell. 2013, 153(6), 1194-1217. https://doi.org/10.1016/j.cell.2022.11.001 |
|
31. |
Heidenreich, B.; Kumar,
R. Tert promoter mutations in telomere biology. Rev. Mut. Res. 2017, 771, 15-31. https://doi.org/10.1016/j.mrrev.2016.11.002 |
|
32. |
Chiu, C.P.; et al.
Telomerase expression in human cells and tissues. Aging Clin. Exp. Res. 1995,
7, 460-461. https://doi.org/10.1007/BF03324363 |
|
33. |
Jacczak, B.; Rubiś, B.;
Totoń, E. Potential of naturally derived compounds in telomerase and telomere
modulation in skin senescence and aging. Int. J. Mol. Sci. 2021, 22(12),
6381. https://doi.org/10.3390/ijms22126381 |
|
34. |
Cé, R.; et al. Estratégias antienvelhecimento
baseadas em moléculas químicas naturais como potentes ativadores de
telomerase. Arq. ciências saúde UNIPAR. 2022. 1229-1247. |
|
35. |
Tsoukalas, D.; et al.
Discovery of potent telomerase activators: unfolding new therapeutic and
anti-aging perspectives. Mol. Med. Rep. 2019, 20(4), 3701-3708. https://doi.org/10.3892/mmr.2019.10614 |
|
36. |
Veverka, P.; Janovič, T.;
Hofr, C. Quantitative biology of human shelterin and telomerase: searching
for the weakest point. Int. J. Mol. Sci. 2019, 20(13), 3186. https://doi.org/10.3390/ijms20133186 |
|
37. |
Castro, I.A. de. p53 protein expression in skin
with different levels of photoaging. Photodermatol. Photoimmunol.
Photomed. 2009, 25(2),
106-108. https://doi.org/10.1111/j.1600-0781.2009.00400.x |
|
38. |
Boonekamp, J.J. et al.
Does oxidative stress shorten telomeres? Biol. Lett. 2017, 13(5), 20170164. https://doi.org/10.1098/rsbl.2017.0164 |
|
39. |
Armstrong, E.; Boonekamp,
J. Does oxidative stress shorten telomeres in vivo? A meta-analysis. Ageing
Res. Rev. 2023, 85, 101854. https://doi.org/10.1016/j.arr.2023.101854 |
|
40. |
Berra, C.M.; Menck, C.F.M.; Di Mascio, P.
Estresse oxidativo, lesões no genoma e processos de sinalização no controle
do ciclo celular. Quím. Nova. 2006, 29, 1340-1344. https://doi.org/10.1590/S0100-40422006000600032 |
|
41. |
Nasir, N.F.M.; et al. Telomeres and oxidative stress. British J.
Med. Med. Res. 2014. 4(1), 57. https://doi.org/10.9734/BJMMR/2014/5548 |
|
42. |
Lin, J.; Epel, E.; Stress
and telomere shortening: insights from cellular mechanisms. Ageing Res. Rev.
2022, 73, 101507. https://doi.org/10.1016/j.arr.2021.101507 |
|
43. |
Coluzzi, E.; Leone, S.; Sgura, A. Oxidative stress induces telomere dysfunction
and senescence by replication fork arrest. Cells. 2019, 8(1), 19. https://doi.org/10.3390/cells8010019 |
|
44. |
Fouquerel, E.; et al.
Oxidative guanine base damage regulates human telomerase activity. Nat.
Struct. Mol. Biol. 2016. 23(12),1092-1100. https://doi.org/10.1038/nsmb.3319 |
|
45. |
Gavia-García, G.; et al.
Telomere length and oxidative stress and its relation with metabolic syndrome
components in the aging. Biology. 2021, 10(4), 253. https://doi.org/10.3390/biology10040253 |
|
46. |
Correia-Melo, C.; Hewitt,
G.; Passos, J.F. Telomeres, oxidative stress and inflammatory factors:
partners in cellular senescence? Long. Health. 2014, 3, 1-9, https://doi.org/10.1186/2046-2395-3-1 |
|
47. |
Berby, B.; et al.
Oxidative stress is associated with telomere interaction impairment and
chromatin condensation defects in spermatozoa of infertile males. Antioxidants, 2021, 10(4), 593. https://doi.org/10.3390/antiox10040593 |
|
48. |
Borson, L.A.M.G.; Romano, L.H. Revisão: o
processo genético de envelhecimento e os caminhos para a longevidade. Revista
Saúde em Foco. 2020, 12, 239-244. |
|
49. |
Casalicchio, A.B.R.; Leonardo, H.A.; D.E.S.;
Gabriella, S. Actions of telomerase
enzyme against physical exercise and aging: studies of the behavior of
telomerase in specific actions imposed. Braz. J. Health Rev. 2022, 5(1),
843-858. https://doi.org/10.34119/bjhrv5n1-073 |
|
50. |
Erusalimsky, Jorge, D.
Oxidative stress, telomeres and cellular senescence: what non-drug
interventions might break the link? Free Rad. Biol. Med. 2020, 150, 87-95. https://doi.org/10.1016/j.freeradbiomed.2020.02.008 |
|
51. |
Ravindranathan, A.; et
al. Preliminary development of an assay for detection of TERT expression,
telomere length, and telomere elongation in single cells. PLoS One. 2018.
13(12), e0206525. https://doi.org/10.1371/journal.pone.0206525 |
|
52. |
Hidema, S.; et al.
Transgenic expression of Telomerase reverse transcriptase (Tert). PLoS One. 2016, 38,19, e96659.
https://doi.org/10.1080/09168451.2016.1191330 |
|
53. |
Rubtsova, M.; et al. Telomere lengthening and other functions of
telomerase. Acta Nat. 2012, 2(13), 44-61, |
|
54. |
Grolimund, L.; et al. A quantitative telomeric chromatin isolation
protocol identifies different telomeric states. Nat. Commun. 2013, 4(1),
2848, https://doi.org/10.1038/ncomms3848 |
|
55. |
Chołjnowski, A. et al.
Progerin reduces LAP2α-telomere association in Hutchinson-Gilford
progeria. eLife, 2015, 4, e07759. https://doi.org/10.7554/eLife.07759 |
|
56. |
Mukherjee, J.; et al.
Mutant IDH1 cooperates with ATRX loss to drive the alternative lengthening of
telomere phenotype in glioma. Cancer Res.
2018, 78(11), 2966-2977. https://doi.org/10.1158/0008-5472.CAN-17-2269 |
|
57. |
Rossiello, F.; et al.
Irreparable telomeric DNA damage and persistent DDR signalling as a shared
causative mechanism of cellular senescence and ageing. Curr. Opin. Gen. Dev. 2014, 26, 89-95.
https://doi.org/ 10.1016/j.gde.2014.06.009 |
|
58. |
Lee, M.; et al. Telomere
extension by telomerase and ALT generates variant repeats by mechanistically
distinct processes. Nucleic Acids Res. 2014, 42(3), 1733-1746.
https://doi.org/10.1093/nar/gkt1117 |
|
59. |
Li, F.; et al. ATRX loss
induces telomere dysfunction and necessitates induction of alternative
lengthening of telomeres during human cell immortalization. EMBO J. 2019. 38(19), e96659. https://doi.org/ 10.15252/embj.201796659 |
|
60. |
Clynes, D.; et al.
Suppression of the alternative lengthening of telomere pathway by the
chromatin remodelling factor ATRX. Nat. Commun. 2015, 6(1), 7538. https://doi.org/ 10.1038/ncomms8538 |
|
61. |
Roake, C.M.; Artandi,
S.E. Regulation of human telomerase in homeostasis and disease. Nat. Rev.
Mol. Cell Biol. 2020, 21 (7), 384-397.
https://doi.org/ 10.1038/s41580-020-0234-z |
|
62. |
Aguado, J.; et al.
Telomere transcription in ageing. Ageing Res. Rev. 2020, 62, 101115, https://doi.org/ 10.1016/j.arr.2020.101115 |
|
63. |
Rossiello, F.; et al.
Telomere dysfunction in ageing and age-related diseases. Nat. Cell Biol. 2022,
24(2),135-147. https://doi.org/ 10.1038/s41556-022-00842-x |
|
64. |
Aubert, G.; Lansdorp,
P.M. Telomeres and aging. Physiol. Rev. 2008, 88(2), 557-579. https://doi.org/10.1152/physrev.00026.2007 |
|
65. |
Victorelli, S.; et al.
Senescent human melanocytes drive skin ageing via paracrine telomere
dysfunction. EMBO J. 2019, 38, 23, e101982. https://doi.org/10.15252/embj.2019101982 |
|
66. |
Ishikawa, N.; et al.
Changes of telomere status with aging: an update. Geriatr. Gerontol. Int.
2016, 16, 30-42. https://doi.org/10.1111/ggi.12772 |
|
67. |
Opresko, P.L.; Shay, J.W.
Telomere-associated aging disorders. Ageing Res. Rev. 2017, 33, 52-66. https://doi.org/10.1016/j.arr.2016.05.009 |
|
68. |
Razdan, N.; Vasilopoulos,
T.; Herbig, U. Telomere dysfunction promotes transdifferentiation of human
fibroblasts into myofibroblasts. Aging
Cell. 2018, 17(6), e12838. https://doi.org/10.1111/acel.12838 |
|
69. |
Victorelli, S.; Passos,
J.F. Telomeres: beacons of autocrine and paracrine DNA damage during skin
aging. Cell Cycle. 2020, 19(5), 532-540. https://doi.org/10.1111/acel.12838 |
|
70. |
Li, S.; et al. Links
between telomere dysfunction and hallmarks of aging. Mut. Res.: Gen. Toxicol.
Environ. Mutagen. 2023, 888, 503617.
https://doi.org/10.1016/j.mrgentox.2023.503617 |
|
71. |
Kalmykova, A. Telomere
checkpoint in development and aging. Int. J. Mol. Sci. 2023, 24(21), 15979. https://doi.org/10.3390/ijms242115979 |
|
72. |
Sengupta, D.; Sengupta,
K. Lamin A and telomere maintenance in aging: Two to tango. Mut. Res.:
Fundament. Mol. Mech. Mut. 2022, 825, 111788. https://doi.org/10.1016/j.mrfmmm.2022.111788 |
|
73. |
Eroschenko, V.P.; Di,
F.M.S.H. Difiore's Atlas of Histology With Functional Correlations. 11. Edn.
Philadelphia: Lippincott Williams and Wilkins, 2014. https://doi.org/10.1111/j.1469-7580.2008.00956.x |
|
74. |
Yousef, H.; Alhajj, M.;
Sharma, S. Anatomy, Skin (Integument), Epidermis. 14 nov. 2022. In:
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2024. |
|
75. |
Arda, O.; Göksügür, N.; Tüzün, Y. Basic histological structure and functions of
facial skin. Clin. Dermatol. 32(1), 3-13. 2014. https://doi.org/10.1016/j.clindermatol.2013.05.021 |
|
76. |
Prost-Squarcioni, C.; et
al. Functional histology of dermis. In:
Ann. Dermatol. Vénéréol. 2008. 135(1 Pt 2), 1S, 5-20.
https://doi.org/10.1016/s0151-9638(08)70206-0 |
|
77. |
Ishida-Yamamoto, A.; et al. Lessons from disorders of epidermal
differentiation-associated keratins. Histol. Histopathol. 2002, 17, 815-822. https://doi.org/10.14670/HH-17.331 |
|
78. |
Khavkin, J.; Ellis, D.A.; Aging skin:
histology, physiology, and pathology. Facial Plastic Surgery Clinics of North
America, 2011, 19(2), 229-234. https://doi.org/10.1016/j.fsc.2011.04.003 |
|
79. |
Ross, M.H.; Pawlina, W. Histologia: Texto e Atlas
Color com Biologia Celular e Molecular. 5. edn. Buenos Aires: Médica
Panamericana, 2015. |
|
80. |
Gartner, L.P.; Hiatt, J.L. Texto Atlas de
Histología. 3. Edn. Cidade do México: McGraw-Hill, 2015. |
|
81. |
Agarwal, S.; Krishnamurthy, K. Histology,
Skin. 1 maio 2023. In: StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing; 2024. https://doi.org/10.7282/t3-kvx1-5747 |
|
82. |
Prost-Squarcioni, C. Histologie de la peau et des follicules pileux. Méd. Sci. 2006. 22(2), 131-137,
https://doi.org/10.1051/medsci/2006222131 |
|
83. |
Gorgoulis, V.; et al. Cellular senescence:
defining a path forward. Cell. 2019, 179(4), 813-827. https://doi.org/10.1016/j.cell.2019.10.005 |
|
84. |
González-Puertos, V.Y.; et al. Participación del
fenotipo secretor de las células senescentes en el desarrollo del cáncer, el
envejecimiento y las enfermedades asociadas a la edad. Gac. Méd. México.
2015, 151(4), 491-500. |
|
85. |
Muñoz-Espín, D.; Serrano, M. Cellular
senescence: from physiology to pathology. Nat. Rev. Mol. Cell Biol. 2014,
15(7), 482-496. https://doi.org/10.1038/nrm3823 |
|
86. |
De Magalhães, S.; Pedro, E. The impact of MAO-A
in cellular senescence. 2014. Tese (Doutorado) – Universidade de Coimbra,
Coimbra, Portugal, 2014. |
|
87. |
Burton, D.G.A.; Krizhanovsky, V. Physiological and pathological consequences of
cellular senescence. Cell. Mol. Life Sci.
2014, 71, 4373-4386. https://doi.org/10.1007/s00018-014-1691-3 |
|
88. |
Dimri, G.P.; et al. A
biomarker that identifies senescent human cells in culture and in aging skin
in vivo. Proceed. Nat. Acad. Sci. 92(20), 1995, 9363-9367. https://doi.org/10.1073/pnas.92.20.9363 |
|
89. |
Adamus, J.; et al.
p16INK4A influences the aging phenotype in the living skin equivalent. J.
Investigat. Dermatol. 2014, 134(4), 1131-1138. https://doi.org/10.1038/jid.2013.468 |
|
90. |
Waaijer, M.E.C. et al.
The number of p16INK4a positive cells in human skin reflects biological age. Aging Cell. 2012, 11(4), 722-725.
https://doi.org/10.1111/j.1474-9726.2012.00837.x |
|
91. |
Oliveira, D.; Félix, P.; et al. Tecnologia para a
qualidade de vida: a pele e as células-tronco. ID on line: Revista de
Psicologia. 2013, 7(19), 103-108. https://doi.org/10.14295/idonline.v7i19.228 |
|
92. |
Zorzanelli, R.T.; et al.
Stem cell research in Brazil: the production of a new field of science. História, Ciências, Saúde-Manguinhos. 2017, 24(1),
129-144. https://doi.org/10.1590/S0104-59702016005000026 |
|
93. |
Forni, M.F.D. Bases moleculares da depleção de
glutationa sobre a pontencialidade, diferenciação e envelhecimento de
células-tronco de pele. Tese de Doutorado. Universidade de São Paulo.
Universidade de São Paulo, 2013.
https://doi.org/10.11606/T.46.2013.tde-10062013-111755 |
|
94. |
Teixeira, I.N.D.; Guariento, M.E. Biologia do
envelhecimento: teorias, mecanismos e perspectivas. Ciência & Saúde
Coletiva. 2010, 15, 2845-2857. DOI: 10.1590/S1413-81232010000600022 |
|
95. |
Campisi, J. Aging, cellular senescence, and
cancer. Ann. Rev. Physiol. 2015, 77, 1-28. https://doi.org/10.1146/annurev-fisiol-030212-183653 |
|
96. |
Rodier, F.; Campisi, J.
Four faces of cellular senescence. J. Cell Biol. 2015, 205(5), 635-644. https://doi.org/10.1083/jcb.201009094 |
|
97. |
Serafim, A.L.; Silva, K.S.O.; Bozzi, A.
Senescência das células-tronco mesenquimais para proposta terapêutica. Rev.
Brasil. Edu. Saúde Bem-estar. 2022, 1(2), 1-15. https://doi.org/10.29327/2335218.1.2-9 |
|
98. |
Guadix, J.A.; Zugaza, J.L.; Gálvez-Martín, P. Characteristics, applications and prospects of
mesenchymal stem cells in cell therapy. Med. Clín. (English Edition), 2017,
148, (9), 408-414. https://doi.org/10.1016/j.medcle.2017.04.018 |
|
99. |
Campisi, J. Cancer, aging
and cellular senescence. In Vivo. 2014, 28(6), 941-951. https://doi.org/10.1146/annurev-physiol-030212-183653 |
|
100. |
Kim, S.H.; Kaminker, P.; Campisi, J.
Telomeres, aging and cancer: in search of a happy ending. Oncogene. 2015,
34(25), 3126-3134. https://doi.org/10.1038/sj.onc.1205077 |
|
101. |
Campisi, J. From cells to organisms: can we
learn about aging from cells in culture? Exp. Gerontol. 2001, 36(4–6), 607-618.
https://doi.org/10.1016/s0531-5565(00)00230-8. |
|
102. |
Alberts, B. et al. Biologia Molecular da Célula.
6. ed. Porto Alegre: Artmed, 2017. ISBN 9780815344322. |
|
103. |
Amaral, C.P. Amaral, E.P.; Reuter, C.P.
Metabolismo celular, genética e estilo de vida. VI Seven International
Multidisciplinary Congress, 2024. https://doi.org/10.56238/sevenVImulti2024-107 |
|
104. |
Childs, B.G.; et al. Cellular senescence in
aging and age-related disease: from mechanisms to therapy. Nat. Med. 2015, 21(12), 1424-1435.
https://doi.org/10.1038/nm.4000 |
|
105. |
Suhre, T. Senescência celular induzida pelo
tratamento combinado de resveratrol e quercetina com butirato de sódio em
glioblastomas. 2012. Dissertação (Mestrado) – Universidade Federal de São
Paulo, São Paulo, 2012. https://doi.org/10183/63720 |
|
106. |
Coppé, J.P.; et al. Senescence-associated
secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and
the p53 tumor suppressor. PLoS Biol. 2008, 6(12), e301. https://doi.org/10.1371/journal.pbio.0060301 |
|
107. |
Chakravarti, D.; Labella, K.A.; Depinho, R.A.
Telomeres: history, health, and hallmarks of aging. Cell. 2021, 184(2),
306-322. https://doi.org/10.1016/j.cell.2020.12.028 |
|
108. |
Santos, D., Tersariol, I.L. Bases moleculares da
longevidade humana: possibilidade de terapias não medicamentosas na promoção
da longevidade. 2021. Tese (Doutorado) – Universidade Fernando Pessoa, Porto,
Portugal, 2021. |
|
109. |
Ferreira, C.P.; et al. Modelagem lógica de
senescência celular humana. 2012. Dissertação (Mestrado) – Universidade
Federal de São Paulo, São Paulo, 2012. |
|
110. |
Hasty, P., Christy, B.A. p53 as an
intervention target for cancer and aging. Pathobiol. Aging Age Relat. Dis.
2013, 3(1), 22702. https://doi.org/10.3402/pba.v3i0.22702 |
|
111. |
Ritschka, B.; et al. The senescence-associated
secretory phenotype induces cellular plasticity and tissue regeneration. Gen.
Dev. 2017, 31(2), 172-183. https://doi.org/10.1101/gad.290635.116 |
|
112. |
Autexier, C.; Lue, N.F. The structure and
function of telomerase reverse transcriptase. Ann. Rev. Biochem. 2015, 84,
1-31. https://doi.org/10.1146/annurev.biochem.75.103004.142412 |
|
113. |
Martínez, P.; Blasco, M.A. Role of shelterin
in cancer and aging. Aging Cell. 2015, 14(5), 749-755. https://doi.org/10.1111/j.1474-9726.2010.00596.x |
|
114. |
Saretzki, G. Telomerase, mitochondria and
oxidative stress. Exp. Gerontol. 2015,
71, 4-8. https://doi.org/10.1016/j.exger.2009.05.004 |
|
115. |
Valdes, A.M.; et al. Leukocyte telomere length is associated with
cognitive performance in healthy women. Neurobiol. Aging, 2016, 41, 32-39. https://doi.org/10.1016/j.neurobiolaging.2008.07.012 |
|
116. |
Cawthon, R.M.; et al. Association between
telomere length in blood and mortality in people aged 60 years or older.
Lancet. 2003, 361(9355), 393-395. https://doi.org/10.1016/S0140-6736(03)12384-7 |
|
117. |
Ruivo, A.P. Envelhecimento cutâneo: fatores
influentes, ingredientes ativos e estratégias de veiculação. Tese (Doutorado)
– Universidade Fernando Pessoa, Porto, Portugal, 2014. |
|
118. |
Cunha, A.F.; et al. Pele: alterações anatômicas e
fisiológicas do nascimento à maturidade. Rev. Saúde em Foco. 2019, 11, 15-30.
|
|
119. |
Bajek, A.; et al. Does aging of mesenchymal stem cells limit their
potential application in clinical practice? Aging Clin. Exp. Res. 2015,
24(5), 404-411. https://doi.org/10.1007/BF03654824 |
|
120. |
Pintado B.L.; et al. GSE4 peptide suppresses
oxidative and telomere deficiencies in ataxia telangiectasia patient cells.
Cell Death Diff. 2019, 26(4), 745-761. https://doi.org/10.1038/s41418-018-0272-7 |
|
121. |
Silva, W.J. Martins, D.F.; Bucalen, C.K.
Metabolismo mitocondrial, radicais livres e envelhecimento. Rev. Brasil.
Geriat. Gerontol. 2015, 14(3), 441-451. https://doi.org/10.1590/S1809-98232011000300005 |
|
122. |
Codd, V. Common variants near TERC are
associated with mean telomere length. Nat. Gen. 2015, 42(3), 197. https://doi.org/10.1038/ng.532. |
|
123. |
Blackburn, E.H.; Epel, E.S.; Lin, J. Human
telomere biology: A contributory and interactive factor in aging, disease
risks, and protection. Science. 2015, 350 (6265), 1193-1198. https://doi.org/10.1126/science.aab3389 |
|
124. |
Campisi, J.; D'adda,
D.F.F. Cellular senescence: when bad things happen to good cells. Nat. Rev.
Mol. Cell Biol. 2007, 8(9),
729-740. https://doi.org/10.1038/nrm2233 |
|
125. |
De Lange, T. Telomere-related genome
instability in cancer. Cold Spring Harbor Symp. Quant. Biol. 2005, 70,
197-204. https://doi.org/10.1101/sqb.2005.70.032 |
|
126. |
Wright, W.E.; Shay, J.W. Telomere dynamics in
cancer progression and prevention: fundamental differences in human and mouse
telomere biology. Nat. Med. 2000, 6, 849-851. https://doi.org/10.1038/78592 |
|
127. |
Panich, U.; et al. Ultraviolet radiation‐induced skin aging: the role of DNA damage and oxidative stress in
epidermal stem cell damage mediated skin aging. Stem Cells Intern. 2016, 1,
7370642. https://doi.org/10.1155/2016/7370642 |
|
128. |
Jennings, B.J.; Ozanne, S.E.; Hales, C.N.
Nutrition, oxidative damage, telomere shortening, and cellular senescence:
individual or connected agents of aging? Mol. Gen. Metabol. 2000, 71(1-2),
32-42. https://doi.org/10.1006/mgme.2000.3077 |
|
129. |
Baur, J.A.; Sinclair, D.A. Therapeutic
potential of resveratrol: the in vivo
evidence. Nat. Rev. Drug Dis. 2006, 5(6), 493-506. https://doi.org/10.1038/nrd2060 |
|
130. |
Zhang, S.; Duan, E. Fighting against skin
aging: the way from bench to bedside. Cell Tran. 2018, 27(5), 729-738.
https://doi.org/10.1177/0963689717725755 |
|
131. |
Pereira, C.A.C.; et al. Mecanismos
fisiopatológicos do envelhecimento. 2015. Dissertação de Mestrado. |
|
132. |
Smith, S. Telomerase can't handle the stress. Gen Dev.
2018, 32, 597-599. https://doi.org/10.316/30643 10.1101/gad.316042.118 |
|
133. |
Wang, Y., Sušac, L., Feigon, J. Structural
Biology of Telomerase. Cold Spring Harbor Persp. Biol. 2018, 11(12), a032383. https://doi.org/10.316/3064310.1101/cshperspect.a032383 |
|
134. |
Sahin, E., Colla, S., Liesa, M.; et al.
Telomere dysfunction induces metabolic and mitochondrial compromise. Nature,
2011, 470 (7334), 359-365. https://doi.org/10.316/3064310.1038/nature09787 |
|
135. |
Maciejowski, J.; De, L.T. Telomeres in cancer:
tumour suppression and genome instability.
Nat. Rev. Mol. Cell Biol. 2017, 18(3), 175-186. https://doi.org/10.316/3064310.1038/nrm.2016.171 |
|
136. |
Deng, Y.; Chang, S. Role of telomeres and
telomerase in genomic instability, senescence and cancer. Lab. Invest. 2007, 87,
11, 1071-1076. https://doi.org/10.1038/labinvest.3700673 |
This work is licensed under the
Creative Commons Attribution
4.0
License (CC BY-NC 4.0).
Abstract
Telomeres are essential structures located at the ends of eukaryotic chromosomes, composed of G-rich repeats, which play a crucial role in protecting chromosomal ends. Telomere shortening is associated with genetic instability and cellular senescence. This review study aims to investigate the role of telomerase in cellular senescence and skin aging. The methodology involved a qualitative exploratory literature review, with research conducted in databases such as PubMed, Web of Science, and Google Scholar. Telomeres protect the ends of eukaryotic chromosomes, and their dysfunction leads to cellular senescence. Telomerase, a ribonucleoprotein, regulates telomere length and is crucial for cellular longevity. However, dysregulated telomerase expression may be associated with pathologies such as cancer. Oxidative stress accelerates telomere shortening and contributes to cellular aging. The analysis revealed a growing trend of publications related to telomeres and telomerase, with peaks in 2020 and 2017, respectively. Cellular senescence showed consistent growth, and exogenous telomerase expression demonstrated therapeutic potential, albeit with associated risks. Telomeres and telomerase play essential roles in regulating cell division and longevity. Telomerase is crucial for preserving cellular function, but its dysregulated expression can lead to pathologies. Oxidative stress accelerates cellular senescence, and research on exogenous telomerase expression highlights both potential and challenges for anti-aging therapies. Understanding these mechanisms is essential for developing effective strategies to promote cellular health and treat age-related diseases.
Abstract Keywords
Telomeres, telomerase, cellular senescence, skin
aging, oxidative stress.
This work is licensed under the
Creative Commons Attribution
4.0
License (CC BY-NC 4.0).
Editor-in-Chief
This work is licensed under the
Creative Commons Attribution 4.0
License.(CC BY-NC 4.0).